Medline HIP CDS-LF Procedure Kit Recall
Areazine synthesizes this FDA recall directly from FDA's official public data feed. See our methodology for full source attribution and refresh cadence.
Medline Industries, LP is recalling 52 HIP CDS-LF procedure kits containing recalled Bupivacaine Hydrochloride in Dextrose Injection due to potential drug ineffectiveness.
What this FDA recall tells you, and what most readers miss
This notice was issued by FDA on August 12, 2026 and geographically references Missouri, Colorado, Illinois. Its severity classification of "high" signals how the issuing agency weighs the risk of harm if no action is taken - "critical" and "high" tier alerts typically carry direct consumer actions, while "medium" and "low" tend toward informational guidance or monitoring advisories. The category it belongs to - FDA Recalls - determines the consumer-protection framework behind it, which shapes what remedies (refunds, replacements, repairs, or the recall itself) are available to affected consumers and which agency holds statutory responsibility for enforcement.
Most readers skim a notice like this, check whether they are personally affected, and move on. The more useful lens is to verify its scope, source, and timestamp, then compare related notices without assuming that one record proves a broader trend.
Areazine pairs this record with the original agency URL so you can check the primary source before acting. Its related labels are recall, product-safety, fda, Devices.
What Happened
Medline Industries, LP initiated a voluntary recall of certain medical procedure convenience kits after determining they contain ICU Medical, Inc. pain management kits with Bupivacaine Hydrochloride in Dextrose Injection, USP, recalled due to quality issues that could result in drug ineffectiveness. The recall is classified as Class I.
Which Products Are Affected
The affected product is the MEDLINE medical procedure convenience kit labeled as HIP CDS-LF, Medline kit SKU CDS984556N. A total of 52 kits are involved, distributed in Missouri, Colorado, and Illinois. Lot numbers include 26EDA285, 26DDA718, 26BDB740, 26ADB079, 26ADA161, 25KDB472, and 25GDA213. UDI/DI codes are 10198459266621 (each) and 40198459266622 (case). Recall number Z-2764-2026.
What You Should Do
Consumers in possession of the affected kits should contact Medline Industries, LP for return or refund information.
Why This Matters
This Class I recall involves a potential risk of drug ineffectiveness in pain management kits included in the procedure kits.
Source
FDA recall Z-2764-2026, recalling firm Medline Industries, LP, Northfield, IL.
Original source: FDA Official Notice ↗
Related FDA Recalls
All FDA Recalls →Nationwide notices with similar length or severity timing 8
Two Areazine-derived peer sets for this FDA recall: nearest notices by body length and by same severity near the same agency date. Peers come from other categories so they are not the same-feed Related list above.
Similar body length
Nearest notices by article body length (1,153 characters here).
Similar severity timing
Same severity (high) notices issued closest in time to August 12, 2026.
Frequently Asked Questions
Common questions about this FDA recall.